SGLT2 Inhibitors Correct Fluid Overload in Adult Kidney Transplant Recipients—A Prospective Observational Study
Transplant International · 2024
DOI: 10.3389/ti.2024.12879 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Transplant International, 2024. Verfasst von Anja Schork und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine IV, Division of Diabetology, Endocrinology, Nephrology, University Hospital Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Kidney Transplantation, Sodium-Glucose Transporter 2 Inhibitors, Glomerular Filtration Rate. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medizinischen Fakultät, Eberhard Karls Universität Tübingen.
Abstract (Originalsprache)
In this longitudinal observational study, we measured urinary glucose concentration, body composition and volume status (bioimpedance spectroscopy) and plasma renin and aldosterone concentrations in n = 22 kidney transplant recipients (KTRs) initiating on SGLT2I at baseline (BL), and after 1 week and 1, 3, and 6 months. Estimated glomerular filtration rate (eGFR) decreased by −2 mL/min/1.73 m 2 (IQR −10–0) after 1 week and remained stable thereafter. Urinary glucose concentration was 10 (3–24) g/g creatinine after 1 week and correlated with eGFR (r 2 = 0.273; p = 0.057). SGLT2I did not affect HbA1c, fasting blood glucose, body weight, fat or lean mass. SGLT2I decreased fluid overload dependent on baseline overhydration (OH, r 2 = 0.54, p = 0.0003) without occurrence of dehydration. Plasma aldosterone increased at day 7, while plasma renin did not change significantly. In conclusion, SGLT2I corrected fluid overload in patients with elevated overhydration at baseline, while in euvolemic KTRs fluid status remained stable without reduction of body water below the reference range, thus promoting the safety of SGLT2I therapy in patients following kidney transplantation. Glucosuria, together with effects of SGLT2I on blood glucose control and body weight, is attenuated in KTRs dependent on eGFR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine IV, Division of Diabetology, Endocrinology, Nephrology, University Hospital Tübingen, Tübingen, Germany.
- Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
- German Center for Diabetes Research (DZD), Tübingen, Germany.
- Department of Cardiology and Nephrology, Sindelfingen Hospital, Sindelfingen, Germany.
- Department of General and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.
Förderung
- Medizinischen Fakultät, Eberhard Karls Universität Tübingen
Zitieren
APA
Schork, A., Eberbach, M. L., Artunc, F., Bohnert, B. N., Eisinger, F., Heister, D. J., Vosseler, D., Nadalin, S., Birkenfeld, A. L., Heyne, N., & Guthoff, M. (2024). SGLT2 Inhibitors Correct Fluid Overload in Adult Kidney Transplant Recipients—A Prospective Observational Study. Transplant International. https://doi.org/10.3389/ti.2024.12879
Vancouver
Schork A, Eberbach ML, Artunc F, Bohnert BN, Eisinger F, Heister DJ, et al. SGLT2 Inhibitors Correct Fluid Overload in Adult Kidney Transplant Recipients—A Prospective Observational Study. Transplant International. 2024. doi:10.3389/ti.2024.12879
BibTeX
@article{Schork2024,
author = {Schork, Anja and Eberbach, Marie-Luise and Artunc, Ferruh and Bohnert, Bernhard N and Eisinger, Felix and Heister, David J and Vosseler, Dorothea and Nadalin, Silvio and Birkenfeld, Andreas L and Heyne, Nils and Guthoff, Martina},
title = {SGLT2 Inhibitors Correct Fluid Overload in Adult Kidney Transplant Recipients—A Prospective Observational Study},
journal = {Transplant International},
year = {2024},
doi = {10.3389/ti.2024.12879}
}
EUVIMED